Health AI's money this week went to tools that pay back fast

The biggest AI financing story this week was a shortfall. On Oct. 30, the Wall Street Journal reported that OpenAI had about $11 billion committed toward a $30 billion round, at a $1.25 trillion valuation, below the $1.4 trillion it first sought.

Health AI had a quieter, steadier week. Between Oct. 27 and Oct. 29, four startups announced rounds totalling $73.5 million, and the products they sell have one thing in common: each makes a concrete promise about time or money saved.

Vera Health: evidence search at clinician scale

Vera Health raised a $28.5 million Series A led by Threshold Ventures, with Mantis VC and SV Angel joining and Y Combinator and Gradient investing again. It has now raised $32 million.

Vera is a search engine that answers clinical questions from more than 60 million biomedical publications, guidelines and FDA and EMA drug labels, and grades the evidence behind each answer.

Its traction is the reason for the round. The company says more than 800,000 users in 190 countries rely on it, and that it reaches about one in four practising physicians in Spain and Italy. It does this with 12 employees.

Midstream Health: AI agents that find money hospitals already earned

Midstream Health raised $20 million led by Valtruis, with Andreessen Horowitz, Foundry and CommonSpirit Ventures continuing. Total funding is $29.2 million.

Midstream reads a health system's contracts, purchasing, pharmacy and payment data, then uses AI agents to chase unclaimed rebates, unenforced pricing terms and payer underpayments. Its customers include CommonSpirit Health, Mount Sinai and Houston Methodist.

• Customers represent more than $100 billion in annual operating expenses and over 250 hospitals.
• The company says it found more than 1,500 recovery opportunities this year.
• It projects $100 million in client savings by the end of 2026, a figure it has not had independently verified.

Midstream delivers within the quarter.

Mike Spadafore, managing director, Valtruis

That line is the thesis of the week in five words. Hospital margins are thin, and a product that recovers cash in the same budget year is an easier sale than one that promises better outcomes in three.

Care delivery: rehab at home and screening in India

The two smaller rounds went to companies that deliver care directly.

• Kivo Health raised $10 million led by Allumia Ventures for virtual pulmonary rehab, starting with COPD. It says it has delivered tens of thousands of sessions and claims it lowers total healthcare spending by $8,245 per member per year.
• Cent, based in India, raised $15 million in equity and debt co-led by Blume Ventures and South Park Commons. It runs full-body screening with AI-consolidated results reviewed by doctors, and bought AI radiology reporting startup Medsee.

The backdrop: digital health funding is steady, not frothy

Rock Health counted $3.7 billion across 114 US digital health deals in the third quarter of 2026, close to the $3.5 billion across 107 deals a year earlier. Year to date, US digital health has raised $11.1 billion.

Set against OpenAI's struggle to fill a $30 billion round, health AI's mid-sized Series A deals look like the more disciplined part of the AI market, and the investors writing them are asking for proof inside a quarter.